Drug intelligence / Profile preview

acetaminophen + caffeine + chlorpheniramine + artificial bezoar

Development stage
Unknown
Lead developer
Zhejiang Dongri Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Compound Cold Capsules (Fufang Ganmao Jiaonang) is a multi-ingredient oral medication widely marketed in China for the symptomatic treatment of the common cold and influenza. The product is a generic combination typically consisting of acetaminophen (an analgesic and antipyretic), chlorpheniramine maleate (an antihistamine), caffeine (a central nervous system stimulant), and artificial bezoar (a traditional Chinese medicine component used for its purported antipyretic and sedative properties). The formulation is designed to alleviate symptoms such as fever, headache, nasal congestion, and sneezing. Dongri Pharmaceutical is one of the manufacturers of this product, offering it in at least two variants, which may differ in the inclusion of additional agents like amantadine hydrochloride. Acetaminophen works by inhibiting prostaglandin synthesis in the central nervous system, while chlorpheniramine competes with histamine for H1-receptor sites on effector cells. Caffeine is included to mitigate the drowsiness often caused by the antihistamine component.

Brand names
Compound Cold Capsules
Other names
复方感冒胶囊Fufang Ganmao JiaonangCompound Paracetamol and Chlorpheniramine Maleate Capsules
02

Targets

ADORA2A (Adenosine A₂A Receptor)ADORA1 (Adenosine receptor A1 subtype)PGHS-1 (Prostaglandin G/H Synthase 1)HRH1 (Histamine H1 Receptor)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on acetaminophen + caffeine + chlorpheniramine + artificial bezoar.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acetaminophen + caffeine + chlorpheniramine + artificial bezoar.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call